ELHAMY ESKANDER, MD
Medical Oncology Physician · FREDERICK, MD
Individual Active NPI 1528050473
Medicare payment data Part B · 2024
| Year | Beneficiaries | Services | Submitted | Allowed | Paid |
|---|---|---|---|---|---|
| 2024 | 899 | 195,010 | $7,074,374 | $4,311,579 | $3,425,075 |
| 2023 | 770 | 177,922 | $6,867,974 | $4,237,307 | $3,363,300 |
| 2022 | 801 | 191,011 | $7,050,556 | $4,300,290 | $3,422,201 |
Top procedures (2024)
| HCPCS | Description | Services | Avg allowed | Avg paid |
|---|---|---|---|---|
| J9271 | Injection, pembrolizumab, 1 mg | 14,200 | $53 | $42 |
| J0881 | Injection, darbepoetin alfa, 1 microgram (non-esrd use) | 11,220 | $3 | $2 |
| J1453 | Injection, fosaprepitant, 1 mg | 10,500 | $0 | $0 |
| Q0138 | Injection, ferumoxytol, for treatment of iron deficiency anemia, 1 mg (non-esrd use) | 9,690 | $0 | $0 |
| J1756 | Injection, iron sucrose, 1 mg | 8,100 | $0 | $0 |
| J9267 | Injection, paclitaxel, 1 mg | 7,645 | $0 | $0 |
| J0897 | Injection, denosumab, 1 mg | 7,380 | $25 | $20 |
| J3380 | Injection, vedolizumab, intravenous, 1 mg | 4,500 | $19 | $15 |
| J2182 | Injection, mepolizumab, 1 mg | 3,300 | $29 | $23 |
| J1569 | Injection, immune globulin, (gammagard liquid), non-lyophilized, (e.g., liquid), 500 mg | 2,620 | $44 | $35 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | 1,876 | $0 | $0 |
| J1626 | Injection, granisetron hydrochloride, 100 mcg | 1,790 | $0 | $0 |
Taxonomy & licensure
| Specialty | Code | Primary | License | State |
|---|---|---|---|---|
| Medical Oncology Physician | 207RX0202X | ✓ | D48184 | MD |
| Hematology & Oncology Physician | 207RH0003X | D0048184 | MD |
Medicare eligibility
- Part B
- Yes
- DME
- Yes
- Home health
- Yes
- Power mobility
- Yes
- Hospice
- Yes
Other Medical Oncology Physician providers in Maryland
- NPI 1174515050
- NPI 1851939052
- NPI 1063780633
- NPI 1275549073
- NPI 1013931526
- NPI 1659688703
- NPI 1427497551
- NPI 1396935649
Source: NPPES (public domain) and CMS Medicare Physician & Other Practitioners data. Not affiliated with CMS, NPPES, or any government agency.